Trial intelligence / Profile preview

PRP vs Viscosupplementation for Knee Degenerative Pathology

NCT01670578Phase 4Completed

Sponsor
Istituto Ortopedico Rizzoli
Start
Feb 2009
Primary completion
Aug 2013
Modality
Adipose-derived MSCs, Bone Marrow MSCs
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of platelet-rich plasma in osteoarthritis (OA) and chondropathy (2 arms), sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: International Knee Documentation Committee Subjective Score at 12 months. Started Feb 2009; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

osteoarthritis (OA)chondropathy

Beyond the preview

Go deeper on NCT01670578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01670578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call